Figure (Pegcetacoplan 01)
Syfovre Injection, Solution
Product Images NDC 73606-020
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Syfovre (NDC 73606-020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Apellis Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Pegcetacoplan 02)
Figure (Pegcetacoplan 03)
Figure (Pegcetacoplan 04)
Figure 1a (Pegcetacoplan 05)
Figure 1b (Pegcetacoplan 06)
Figure 2 (Pegcetacoplan 07)
Figure 3a (Pegcetacoplan 08)
Figure 3b (Pegcetacoplan 09)
Figure 3c (Pegcetacoplan 10)
Figure 4 (Pegcetacoplan 11)
Figure 5 (Pegcetacoplan 12)
Chemical Formula (Pegcetacoplan 13)
Figure 1 (Pegcetacoplan 14)
Figure 2 (Pegcetacoplan 15)
Principal Display Panel (15 mg Vial Carton)
Apellis NDC 73606-020-01 is a medication available in a single-dose vial for intravitreal use. The medication contains 15 mg of pegeetacoplan injection, which is a 0.1 mL solution with a concentration of 150 mg/mL. The label instructs to discard any unused portion. The text does not provide information about the medication's indications or side effects.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
